|

Lutetium (177Lu) rhPSMA-10.1 Injection Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 177Lu-rhPSMA-10.1

Pipeline

Phase 1/2: 1

Top Sponsors

  • Blue Earth Therapeutics Ltd1

Indications

  • Prostatic Diseases1
  • Urogenital Neoplasms1
  • mCRPC1
  • Metastatic Castration-resistant Prostate Cancer1
  • Prostatic Neoplasms1

Miami, Florida1 trial

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

Biogenix Molecular LLC

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.